Related references
Note: Only part of the references are listed.Withaferin A and its potential role in glioblastoma (GBM)
Jasdeep Dhami et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
EXTH-30. TUMOR TREATING FIELDS (TTFIELDS) INDUCE AUTOPHAGY IN GLIOMA CELLS
Yaara Porat et al.
NEURO-ONCOLOGY (2017)
IMST-30. EVALUATING THE IN-VITRO EFFECTS OF TUMOR-TREATING FIELDS ON T-CELL RESPONSES
Gil Diamant et al.
NEURO-ONCOLOGY (2017)
EXTH-25. EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) AND TEMOZOLOMIDE IN MGMT EXPRESSING AND NON-EXPRESSING PATIENT-DERIVED GLIOBLASTOMA CELLS
Paul Clark et al.
NEURO-ONCOLOGY (2017)
NIMG-39. CYTOSTATIC AGENTS COMBINED WITH TUMOR TREATING FIELDS (TTFIELDS) IN GLIOMA CELL LINES
Morris Groves et al.
NEURO-ONCOLOGY (2017)
EXTH-07. TUMOR-TREATING-FIELD (TTFIELD) EFFECTS ON GLIOBLASTOMA CELLS ARE AUGMENTED BY MITOTIC CHECKPOINT INHIBITION
Almuth F. Kessler et al.
NEURO-ONCOLOGY (2017)
IMST-26. TUMOR TREATING FIELDS EXPOSURE OF TUMOR CELLS INDUCE ACTIVATION PHENOTYPE IN IMMUNE CELLS
Talia Holtzman
NEURO-ONCOLOGY (2017)
AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
Edwin Chang et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Tumor treating fields: a novel treatment modality and its use in brain tumors
Andreas F. Hottinger et al.
NEURO-ONCOLOGY (2016)
Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation
Eun Ho Kim et al.
ONCOTARGET (2016)
Fast and high temperature hyperthermia coupled with radiotherapy as a possible new treatment for glioblastoma
Giovanni Borasi et al.
JOURNAL OF THERAPEUTIC ULTRASOUND (2016)
Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
George Ansstas et al.
CASE REPORTS IN NEUROLOGY (2016)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A
Lokesh Gambhir et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study
Aafia Chaudhry et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
Moshe Giladi et al.
SCIENTIFIC REPORTS (2015)
Glioblastoma: From Molecular Pathology to Targeted Treatment
Timothy F. Cloughesy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ
Karen Heyninck et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields
Moshe Giladi et al.
PANCREATOLOGY (2014)
Imaging Circulating Tumor Cells in Freely Moving Awake Small Animals Using a Miniaturized Intravital Microscope
Laura Sarah Sasportas et al.
PLOS ONE (2014)
Standards of care and novel approaches in the management of glioblastoma multiforme
Andreas F. Hottinger et al.
CHINESE JOURNAL OF CANCER (2014)
Tumor treating fields: a new frontier in cancer therapy
Angela M. Davies et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1
Chenfei Zhou et al.
MOLECULAR CANCER (2013)
Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis
Sandro Santagata et al.
ACS CHEMICAL BIOLOGY (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses
Hong-Bin Fang et al.
STATISTICS IN MEDICINE (2008)
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Paola Bargagna-Mohan et al.
CHEMISTRY & BIOLOGY (2007)
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N. Sarkaria et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: Potential application to choroidal neovascularization
Paola Bargagna-Mohan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Perturbation of actin dynamics induces NF-κB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway
G Kustermans et al.
BIOCHEMICAL JOURNAL (2005)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
Disruption of the actin cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultured human intestinal epithelial cells
ZH Németh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Share Paper
